Association of the adiponectin gene rs1501299 G>T variant, serum adiponectin levels, and the risk of coronary artery disease in a Chinese population

Diabetes Research and Clinical Practice

Volumn 97, Issue 3, 2012, Pages 499-504

  Gui, Ming Hui ^a   Li, Xiang ^b   Jiang, Sun Fang ^a   Gao, Jian ^a   Lu, Da Ru ^c   Gao, Xin ^a  

^a FUDAN UNIVERSITY   (China)

^b DALIAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Adiponectin; Coronary artery disease; Gene; Polymorphism

Indexed keywords

ADIPONECTIN; GUANINE; THYMINE;

ADIPOQ GENE; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPONECTIN; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84866554609     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.05.011     Document Type: Article

References (30)

1. Meilleur K.G., Doumatey A., Huang H., Charles B., Chen G., Zhou J., et al. Circulating adiponectin is associated with obesity and serum lipids in West Africans. J Clin Endocrinol Metab 2010, 95(July(7)):3517-3521.
2. Siitonen N., Pulkkinen L., Lindström J., Kolehmainen M., Eriksson J.G., Venojärvi M., et al. Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study. BMC Med Genet 2011, January(12):5.
3. Kajikawa Y., Ikeda M., Takemoto S., Tomoda J., Ohmaru N., Kusachi S. Association of circulating levels of leptin and adiponectin with metabolic syndrome and coronary heart disease in patients with various coronary risk factors. Int Heart J 2011, 52(1):17-22.
4. Nakatochi M., Miyata S., Tanimura D., Izawa H., Asano H., Murase Y., et al. The ratio of adiponectin to homeostasis model assessment of insulin resistance is a powerful index of each component of metabolic syndrome in an aged Japanese population: Results from the KING Study. Diabetes Res Clin Pract 2011, 92(June(3)):e61-e65.
5. Vionnet N., Hani E.H., Dupont S., Gallina S., Francke S., Dotte S., et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and indepent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 2000, 67(December(6)):1470-1480.
6. Francke S., Manraj M., Lacquemant C., Lecoeur C., Leprêtre F., Passa P., et al. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet 2001, 10(November(24)):2751-2765.
7. Kissebah A.H., Sonnenberg G.E., Myklebust J., Goldstein M., Broman K., James R.G., et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A 2000, 97(December(26)):14478-14483.
8. Bacci S., Menzaghi C., Ercolino T., Ma X., Rauseo A., Salvemini L., et al. The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. Diabetes Care 2004, 27(August(8)):2015-2020.
9. Hu F.B., Doria A., Li T., Meigs J.B., Liu S., Memisoglu A., et al. Genetic variation at the adiponectin locus and risk of type 2 diabetes in women. Diabetes 2004, 53(January(1)):209-213.
10. Gu H.F., Abulaiti A., Ostenson C.G., Humphreys K., Wahlestedt C., Brookes A.J., et al. Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APMl) gene are associated with type 2 diabetes in Swedish Caucasians. Diabetes 2004, 53(February(Suppl. 1)):S31-S35.
11. Vasseur F., Helbecque N., Dina C., Lobbens S., Delannoy V., Gaget S., et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APMl gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002, 11(October(21)):2607-2614.
12. Chiodini B.D., Specchia C., Gori F., Barlera S., D'Orazio A., Pietri S., et al. Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: an association study in an Italian population. Ther Adv Cardiovasc Dis 2010, 4(August(4)):223-230.
13. Hara K., Boutin P., Mori Y., Tobe K., Dina C., Yasuda K., et al. Genetic variation in the gene encoding adiponectin is associated with increased risk of type 2 diabetes. Diabetes 2002, 51(February(2)):536-540.
14. Katakami N., Kaneto H., Matsuoka T.A., Takahara M., Maeda N., Shimizu I., et al. Adiponectin G276T gene polymorphism is associated with cardiovascular disease in Japanese patients with type 2 diabetes. Atherosclerosis 2012, 220(February(2)):437-442.
15. Hwang J.Y., Park J.E., Choi Y.J., Huh K.B., Kim W.Y. SNP276G>T polymorphism in the adiponectin gene is associated with metabolic syndrome in patients with type II diabetes mellitus in Korea. Eur J Clin Nutr 2010, 64(January(1)):105-107.
16. Lee Y.Y., Lee N.S., Cho Y.M., Moon M.K., Jung H.S., Park Y.J., et al. Genetic association study of adiponectin polymorphisms with risk of Type 2 diabetes mellitus in Korean population. Diabet Med 2005, 22(May(5)):569-575.
17. Gui M.H., Qin G.Y., Ning G., Hong J., Li X.Y., Gao X., et al. The comparison of coronary angiographic profiles between diabetic and nondiabetic patients with coronary artery disease in a Chinese population. Diabetes Res Clin Pract 2009, 85(August(2)):213-219.
18. Fiévet C., Nuttens M.C., Ducimetière P., Fruchart J.C., Bertrand M., Salomez J.L. Relation of arteriographically defined coronary artery disease to serum lipoprotein particles mapped with monoclonal antibodies. Circulation 1991, 84(July(1)):153-159.
19. Wolk R., Berger P., Lennon R.J., Brilakis E.S., Davison D.E., Somers V.K. Association between plasma adiponectin levels and unstable coronary syndromes. Eur Heart J 2007, 28(February(3)):292-298.
20. Snijder M.B., Heine R.J., Seidell J.C., Bouter L.M., Stehouwer C.D., Nijpels G., et al. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study. Diabetes Care 2006, 29(November(11)):2498-2503.
21. Ohashi T., Shibata R., Morimoto T., Kanashiro M., Ishii H., Ichimiya S., et al. Correlation between circulating adiponectin levels and coronary plaque regression during aggressive lipid-lowering therapy in patients with acute coronary syndrome: subgroup analysis of JAPAN-ACS study. Atherosclerosis 2010, 212(September(1)):237-242.
22. Shibata S., Tada Y., Hau C., Tatsuta A., Yamamoto M., Kamata M., et al. Adiponectin as an anti-inflammatory factor in the pathogenesis of psoriasis: induction of elevated serum adiponectin levels following therapy. Br J Dermatol 2011, 164(March(3)):667-670.
23. Jang Y., Chae J.S., Koh S.J., Hyun Y.J., Kim J.Y., Jeong Y.J., et al. The influence of the adiponectin gene on adiponectin concentrations and parameters of metabolic syndrome in non-diabetic Korean women. Clin Chim Acta 2008, 391(May(1-2)):85-90.
24. Sun K., Li Y., Wei C., Tong Y., Zheng H., Guo Y. Recessive protective effect of ADIPOQ rs1501299 on cardiovascular diseases with type 2 diabetes: a meta-analysis. Mol Cell Endocrinol 2012, 349(February(2)):162-169.
25. Qi L., Li T., Rimm E., Zhang C., Rifai N., Hunter D., et al. The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes 2005, 54(May(5)):1607-1610.
26. Mousavinasab F., Tähtinen T., Jokelainen J., Koskela P., Vanhala M., Oikarinen J., et al. Commom polymorphisms (single-nucleotide polymorphysims SNP+45 and SNP+276) of the adiponectin gene regulate serum adiponectin concentrations and blood pressure in young Finnish men. Mol Genet Metab 2006, 87(February(2)):147-151.
27. Jang Y., Lee J.H., Chae J.S., Kim O.Y., Koh S.J., Kim J.Y., et al. Association of 276G>T polymorphism of the adiponectin gene with cardiovascular disease risk factors in nondiabetic Koreans. Am J Clin Nutr 2005, 82(October(4)):760-767.
28. Filippi E., Sentinelli F., Romeo S., Arca M., Berni A., Tiberti C., et al. The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adipnectin in younger coronary artery disease patients (age < or =50 years). J Mol Med 2005, 83(September(9)):711-719.
29. Leu H.B., Chung C.M., Lin S.J., Jong Y.S., Pan W.H., Chen J.W. Adiponectin gene polymorphism is selectively associated with the concomitant presence of metabolic syndrome and essential hypertension. PLoS One 2011, 6(5):e19999.
30. Al-Daghri N.M., Al-Attas O.S., Alokail M.S., Alkharfy K.M., Hussain T., Yakout S., et al. Adiponectin gene polymorphisms (T45G and G276T), adiponectin levels and risk for metabolic diseases in an Arab population. Gene 2012, 493(February(1)):142-147.